INM
InMed Pharmaceuticals Inc
NASDAQ: INM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.70
+0.00% today
Updated 2026-04-29
Market cap
$2.43M
P/E ratio
—
P/S ratio
0.54x
EPS (TTM)
$-2.88
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
InMed Pharmaceuticals Inc (INM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+1.2%
Most recent quarter
EPS YoY growth
+85.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.3%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-11.4%
2026-02-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $-0.51 | — | $0.99 | $0.88 | -11.4% |
| 2025-11-13 | $-0.44 | — | $1.73 | $1.71 | -1.4% |
| 2025-09-29 | $-1.20 | — | $2.19 | $2.19 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.51 | — | $1.13M | +1.2% |
| 2025-09-30 | — | $-0.44 | — | $1.12M | -11.4% |
| 2025-06-30 | — | $-1.20 | — | $1.78M | +38.5% |
| 2025-03-31 | — | $-1.94 | — | $1.26M | +7.6% |
| 2024-12-31 | — | $-3.64 | — | $1.11M | -10.4% |
| 2024-09-30 | — | $-0.22 | — | $1.26M | +40.2% |
| 2024-06-30 | — | $-0.22 | — | $1.28M | -44.5% |
| 2024-03-31 | $-0.18 | $-0.18 | +0.4% | $1.17M | — |
| 2023-12-31 | $-5.50 | $-14.03 | -155.1% | $1.24M | — |
| 2023-09-30 | $-0.22 | $-0.10 | +53.8% | $901862.00 | — |
| 2023-06-30 | $-4.25 | $-3.25 | +23.5% | $2.31M | — |
Frequently asked questions
Has InMed Pharmaceuticals Inc beaten earnings estimates?
InMed Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does INM stock react to earnings?
INM stock has moved an average of -4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is InMed Pharmaceuticals Inc's revenue growth rate?
InMed Pharmaceuticals Inc reported year-over-year revenue growth of +1.2% in its most recent quarter, with EPS growing +85.9% year-over-year.